• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

J Neurol . Delirium in hospitalized COVID-19 patients: a prospective, multicenter, cohort study

tetano

Editor, Senior Moderator
J Neurol


. 2023 Jul 30.
doi: 10.1007/s00415-023-11882-0. Online ahead of print. Delirium in hospitalized COVID-19 patients: a prospective, multicenter, cohort study

Wei Zhu[SUP] #[/SUP][SUP] 1 [/SUP], Yangjing Bai[SUP] #[/SUP][SUP] 2 [/SUP], Simin Li[SUP] 3 [/SUP], Meng Zhang[SUP] 4 [/SUP], Jian Chen[SUP] 5 [/SUP], Peishan Xie[SUP] 6 [/SUP], Xuejiao Bai[SUP] 6 [/SUP], Dong Zhou[SUP] #[/SUP][SUP] 7 [/SUP], Yan Jiang[SUP] #[/SUP][SUP] 8 [/SUP]



Affiliations
Abstract

Background: Delirium is a prevalent symptom of acute brain dysfunction caused by Coronavirus disease 2019 (COVID-19). However, the understanding of delirium in COVID-19 patients is currently limited. This study aimed to investigate the prevalence of delirium and its risk factors in hospitalized COVID-19 patients for early identification and management of delirium.
Methods: This cohort study included hospitalized patients with SARS-CoV-2 infection at seven tertiary hospitals from January to February 2023. Delirium was assessed at a single time point using the 3-Minute Diagnostic Assessment for Delirium by trained research assistants. Demographic data, clinical characteristics, in-hospital mortality and other variables were collected from health information system. Multivariate regression analyses were conducted to investigate the risk factors for delirium and the impact of delirium on in-hospital mortality.
Results: A total of 4589 COVID-19 patients were included, out of which 651 cases (14.2%) were identified as delirium. In the multivariable analysis, aging (OR 3.58 [95%CI 2.75-4.67], p < 0.001), higher aspartic transaminase/alanine transaminase ratio (OR = 1.11, [95%CI 1.02-1.21], p = 0.018), Mg[SUP]2+[/SUP] (OR = 3.04, [95%CI 2.56-3.62], p < 0.001), blood urea nitrogen (OR = 1.01, [95%CI 1.00, 1.02], p = 0.024), and indwelling urethral catheterization (OR = 1.59, [95%CI 1.21, 2.09], p < 0.001) were associated with an increased risk of delirium. After adjusting for age, sex, and CCI, delirium was found to be associated with an increased risk of in-hospital mortality (OR = 2.42, [95%CI 1.59, 3.67], p < 0.001).
Conclusion: Delirium was a frequent complication among hospitalized COVID-19 patients and was related to unfavorable outcomes. It is crucial to reduce delirium and its long-term effects by addressing the modifiable risk factors.

Keywords: Infection; Mortality; Multiple imputation; Risk factor; SARS-CoV-2.

 
Back
Top Bottom